Louise Yelle

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer

Stephen Chan, Kay Friedrichs, D. Noel et al. · Journal of Clinical Oncology · 1999 · 638 citations

Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

Peter A. Kaufman, Ahmad Awada, Chris Twelves et al. · Journal of Clinical Oncology · 2015 · 442 citations · Full text

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, As First-Line Therapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline Chemotherapy

Henri Roché, Louise Yelle, Francesco Cognetti et al. · Journal of Clinical Oncology · 2007 · 225 citations

Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.

Jean Latreille, Joseph L. Pater, D. Johnston et al. · Journal of Clinical Oncology · 1998 · 117 citations

Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG)

Maureen Trudeau, Michael Crump, Danielle Charpentier et al. · Annals of Oncology · 2006 · 113 citations · Full text

National Cancer Institute, Metastatic Breast Cancer, Breast Oncology +8